Boni E. Elewski

18.0k total citations · 2 hit papers
291 papers, 10.5k citations indexed

About

Boni E. Elewski is a scholar working on Epidemiology, Dermatology and Cell Biology. According to data from OpenAlex, Boni E. Elewski has authored 291 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Epidemiology, 107 papers in Dermatology and 75 papers in Cell Biology. Recurrent topics in Boni E. Elewski's work include Nail Diseases and Treatments (156 papers), Fungal Infections and Studies (91 papers) and Plant Pathogens and Fungal Diseases (72 papers). Boni E. Elewski is often cited by papers focused on Nail Diseases and Treatments (156 papers), Fungal Infections and Studies (91 papers) and Plant Pathogens and Fungal Diseases (72 papers). Boni E. Elewski collaborates with scholars based in United States, Canada and Italy. Boni E. Elewski's co-authors include Mahmoud A. Ghannoum, K. Wade Foster, David M. Pariser, Mark Lebwohl, Kim Papp, Phoebe Rich, Richard G. Langley, Bárður Sigurgeirsson, Antonellá Tosti and Aditya K. Gupta and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Gastroenterology.

In The Last Decade

Boni E. Elewski

286 papers receiving 9.9k citations

Hit Papers

Secukinumab in Plaque Pso... 2014 2026 2018 2022 2014 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
    2014 1.5k citations Richard G. Langley, Boni E. Elewski et al. profile →
  2. Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*
    2020 213 citations Jonathan I. Silverberg, D. Toth et al. British Journal of Dermatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Boni E. Elewski 5.6k 3.9k 3.3k 2.7k 998 291 10.5k
Sunil Dogra 1.8k 0.3× 1.5k 0.4× 793 0.2× 1.1k 0.4× 982 1.0× 347 5.0k
Seymour Katz 2.5k 0.4× 1.3k 0.3× 628 0.2× 4.1k 1.5× 374 0.4× 248 11.0k
Peter Fritsch 1.4k 0.3× 2.0k 0.5× 977 0.3× 4.1k 1.5× 372 0.4× 246 9.9k
Robert Sabat 2.2k 0.4× 4.1k 1.1× 190 0.1× 7.5k 2.7× 719 0.7× 171 13.4k
Jan D. Bos 552 0.1× 4.4k 1.1× 950 0.3× 4.4k 1.6× 135 0.1× 131 9.3k
J.Q. Del Rosso 1.7k 0.3× 4.3k 1.1× 1.1k 0.3× 584 0.2× 497 0.5× 590 6.3k
J.D. Bos 600 0.1× 3.5k 0.9× 687 0.2× 3.0k 1.1× 203 0.2× 123 6.9k
Devinder Mohan Thappa 953 0.2× 1.6k 0.4× 586 0.2× 570 0.2× 552 0.6× 361 4.2k
Helgi Valdimarsson 1.1k 0.2× 2.2k 0.6× 214 0.1× 5.1k 1.8× 598 0.6× 173 8.2k
W.J. Cunliffe 874 0.2× 4.4k 1.1× 1.3k 0.4× 627 0.2× 522 0.5× 145 6.6k

Countries citing papers authored by Boni E. Elewski

Since Specialization
Citations

This map shows the geographic impact of Boni E. Elewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boni E. Elewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boni E. Elewski more than expected).

Fields of papers citing papers by Boni E. Elewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boni E. Elewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boni E. Elewski. The network helps show where Boni E. Elewski may publish in the future.

Co-authorship network of co-authors of Boni E. Elewski

This figure shows the co-authorship network connecting the top 25 collaborators of Boni E. Elewski. A scholar is included among the top collaborators of Boni E. Elewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boni E. Elewski. Boni E. Elewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Augustin, Matthias, Alice B. Gottlieb, Yayoi Tada, et al.. (2024). 51782 Generalized pustular psoriasis (GPP) continues to adversely impact quality of life between flares, as per Dermatology Life Quality Index scores: Baseline data from the Effisayil 2 trial. Journal of the American Academy of Dermatology. 91(3). AB220–AB220. 1 indexed citations
2.
Merola, Joseph F., Alice B. Gottlieb, Andreas Pinter, et al.. (2024). Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials. Dermatology and Therapy. 14(12). 3291–3306. 2 indexed citations
3.
Kashyap, Mahendra, Bharat Mishra, R. Sinha, et al.. (2024). CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa. Proceedings of the National Academy of Sciences. 121(48). e2409274121–e2409274121. 3 indexed citations
4.
Joseph, Warren S., et al.. (2024). Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison. Dermatology and Therapy. 14(9). 2495–2507. 3 indexed citations
5.
Lipner, Shari R., Tracey C. Vlahovic, Mahmoud A. Ghannoum, Boni E. Elewski, & Warren S. Joseph. (2024). Dermatophytomas in Onychomycosis: A Scoping Review of Prevalence, Diagnosis, and Treatment. Journal of the American Podiatric Medical Association. 114(2). 3 indexed citations
6.
Cruz, Claudia de la, Akimichi Morita, Boni E. Elewski, et al.. (2023). 43751 Efficacy and safety of spesolimab for generalized pustular psoriasis treatment according to flare trigger. Journal of the American Academy of Dermatology. 89(3). AB42–AB42. 1 indexed citations
7.
Elewski, Boni E., Mark Lebwohl, Milan J. Anadkat, et al.. (2023). Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study. Journal of the American Academy of Dermatology. 89(1). 36–44. 21 indexed citations
8.
Jin, Lin, Yunjia Chen, Suhail Muzaffar, et al.. (2023). Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. Proceedings of the National Academy of Sciences. 120(49). e2315096120–e2315096120. 10 indexed citations
9.
Elewski, Boni E., et al.. (2023). Hidradenitis Suppurativa and Five Key Vitamins and Minerals. Skin Appendage Disorders. 9(3). 153–159. 3 indexed citations
10.
Gamal, Ahmed, Mohammed Elshaer, Lisa Long, et al.. (2023). Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds. Journal of the American Podiatric Medical Association. 114(5). 6 indexed citations
11.
Elewski, Boni E., et al.. (2023). New Onset Generalized Pustular Psoriasis Rapidly Improved with IL-36 Blockade. SKIN The Journal of Cutaneous Medicine. 7(1). 585–588. 2 indexed citations
12.
Blauvelt, Andrew, C. Leonardi, Boni E. Elewski, et al.. (2020). A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*. British Journal of Dermatology. 184(6). 1047–1058. 73 indexed citations
13.
Silverberg, Jonathan I., D. Toth, Thomas Bieber, et al.. (2020). Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*. British Journal of Dermatology. 184(3). 450–463. 213 indexed citations breakdown →
14.
Cantrell, Wendy, et al.. (2019). Treatment of Tinea Capitis. Skin Appendage Disorders. 5(4). 201–210. 34 indexed citations
15.
Elmets, Craig A., Jaye L. Viner, Alice P. Pentland, et al.. (2010). Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial. JNCI Journal of the National Cancer Institute. 102(24). 1835–1844. 167 indexed citations
16.
Elewski, Boni E.. (1997). Bacterial infection in a patient with onychomycosis. Journal of the American Academy of Dermatology. 37(3). 493–494. 1 indexed citations
17.
18.
Fariello, R, C Alicandri, Boni E. Elewski, Augusto Zaninelli, & G Muiesan. (1985). Hemodynamic and humoral changes induced by pinacidil a new vasodilator drug in mild to moderate hypertensives. Clinical Pharmacology & Therapeutics. 37(2). 195. 2 indexed citations
19.
Elewski, Boni E., et al.. (1985). Eruptive Lesions and Malignancy. International Journal of Dermatology. 24(10). 617–629. 15 indexed citations
20.
Fariello, R, M.L. Muiesan, C Alicandri, et al.. (1984). Effects of prizidilol skf 92657 on hemodynamics catecholamines and the renin aldo sterone angiotensin system in essential hypertensive patients. Clinical Trials. 21(2). 67–79. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunil Dogra Breakdown of academic impact, for papers by Seymour Katz Breakdown of academic impact, for papers by Peter Fritsch Breakdown of academic impact, for papers by Robert Sabat Breakdown of academic impact, for papers by Jan D. Bos Breakdown of academic impact, for papers by J.Q. Del Rosso Breakdown of academic impact, for papers by J.D. Bos Breakdown of academic impact, for papers by Devinder Mohan Thappa Breakdown of academic impact, for papers by Helgi Valdimarsson Breakdown of academic impact, for papers by W.J. Cunliffe
Rankless by CCL
2026